Abstract
The effect of YS980, an angiotensin-converting enzyme inhibitor, on the generation of medullary prostaglandins E2 and F2 alpha was examined. At concentrations of 0.2 mM and below, YS980 enhanced prostaglandin F2 alpha synthesis at the expense of prostaglandin E2. At concentrations of 0.4 mM or more, YS980 inhibited synthesis of both prostaglandins E2 and F2 alpha markedly. These results suggest that YS980 has the potential to modulate prostaglandins E2 and F2 alpha synthesis by the kidney and that this effect may represent some pharmacological action of the drug.
MeSH terms
-
3-Mercaptopropionic Acid / analogs & derivatives
-
3-Mercaptopropionic Acid / pharmacology*
-
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
-
Animals
-
Aspirin / pharmacology
-
Dinoprost
-
Dinoprostone
-
In Vitro Techniques
-
Kidney Medulla / drug effects*
-
Kidney Medulla / metabolism
-
Male
-
Prostaglandins E / biosynthesis*
-
Prostaglandins F / biosynthesis*
-
Rabbits
-
Sulfhydryl Compounds
-
Thiazolidines
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Prostaglandins E
-
Prostaglandins F
-
Sulfhydryl Compounds
-
Thiazolidines
-
(4R)-3-((2S)-3-mercapto-2-methylpropanoyl)-4- thiazolidinecarboxylic acid
-
3-Mercaptopropionic Acid
-
Dinoprost
-
Dinoprostone
-
Aspirin